Future costs in cost-effectiveness analysis: An empirical assessment

Kruse, Marie, Soerensen, Jan and Gyrd-Hansen, Dorte (2012) Future costs in cost-effectiveness analysis: An empirical assessment. European Journal of Health Economics, 13 1: 63-70.

Attached Files (Some files may be inaccessible until you login with your UQ eSpace credentials)
Name Description MIMEType Size Downloads

Author Kruse, Marie
Soerensen, Jan
Gyrd-Hansen, Dorte
Title Future costs in cost-effectiveness analysis: An empirical assessment
Journal name European Journal of Health Economics  (ERA 2012 Listed)    (ERA 2010 Rank B)   Check publisher's open access policy
Publication date 2012-02
Sub-type Article
DOI 10.1007/s10198-010-0280-0
Volume number 13
Issue number 1
ISSN 1618-7598; 1618-7601
Start page 63
End page 70
Total pages 8
Place of publication Heidelberg, Germany
Publisher Springer
Collection year 2013
Language eng
Formatted abstract Aim: The aim of this study was to assess the impact on the cost-effectiveness ratio of including measures of production and consumption following a health care or health promotion intervention that improves survival.
Data and methods: We defined the net incremental consumption, or future costs, as the change in consumption minus change in production, while differentiating between health care and non-health care consumption. Based on 2005 register-based data for the entire Danish population, we estimated the average value of annual production and consumption for 1-year age groups. We computed the net consumption in the remaining expected lifetime and the net consumption per life year gained for different age groups.
Results: Age has a profound effect on the magnitude of net consumption. When including net incremental consumption in the cost-effectiveness ratio of a health care or health promotion intervention, the relative cost-effectiveness changed up to €21,000 across age groups. The largest difference in the cost-effectiveness ratio was observed among the 30-year-olds where costs were reduced significantly due to significant future net contributions to society.
Conclusion: This paper contains cost figures for use in cost-effectiveness analyses, when the societal perspective is adopted and future consumption and production effects are taken into account. The net consumption varies considerably with age. Inclusion of net incremental consumption in the cost-effectiveness analysis will markedly affect the relative cost-effectiveness of interventions targeted at different age groups. Omitting future cost from cost-effectiveness analysis may bias the ranking of health care interventions and favour interventions aimed at older age groups. We used Danish data for this assessment, and our results will therefore not represent true figures for other countries. We do, however, believe that the overall impact of including net production value in CEA will be similar in other countries that have similar transfers of income from the younger age groups to older age groups as well as publicly financed social and health care services.
Keyword Future costs
Cost-effectiveness analysis
Cost-effectiveness analysis
Q-Index Code C1
Q-Index Status Confirmed Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article
Collections: Official 2013 Collection
Admin Only - School of Medicine
School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 2 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 0 times in Scopus Article
Google Scholar Search Google Scholar
Access Statistics: 40 Abstract Views, 1 File Downloads  -  Detailed Statistics
Created: Thu, 20 Oct 2011, 13:26:45 EST by Dorte Gyrd-hansen on behalf of Medicine - Royal Brisbane and Women's Hospital